Literature DB >> 29982016

Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology.

Roselena S Schuh1, Édina Poletto2, Flávia N S Fachel3, Ursula Matte2, Guilherme Baldo2, Helder F Teixeira4.   

Abstract

In this study, we investigated the effects of the association of a single plasmid or its co-complexation along with an oligonucleotide on the physicochemical properties of cationic nanoemulsions and liposomes intended for gene editing. Formulations composed of DOPE, DOTAP, DSPE-PEG (liposomes), MCT (nanoemulsions), and water were obtained by microfluidization. DSPE-PEG was found to play a crucial role on the size and polydispersity index of nanocarriers. Nucleic acids were complexated by adsorption at different charge ratios. No significant differences were noticed in the physicochemical properties of nanocarriers (i.e. droplet size, polydispersity index, or zeta potential) when a single plasmid or both plasmid and oligonucleotide were adsorbed to the formulations. Transmission electron microscopy photomicrographs suggested round nanostructures with the nucleic acids and DSPE-PEG enfolding the surface. Complexes at +4/-1 charge ratio protected nucleic acids against DNase I degradation. The oligonucleotide seemed to be released from the liposomal complexes, while nanoemulsions only released the plasmid after 24 and 48 h of incubation in DMEM supplemented or not. In vitro experiments demonstrated that complexes were highly tolerable to human fibroblasts, Hep-G2, and HEK-293 cells, demonstrating also an uptake ability of about 30%, 30%, and 90%, respectively, no matter what the formulation or the combination of nucleic acids used. Transfection efficiency of the formulations was around 25% in human fibroblasts, 32% in HEK-293, and 15% in Hep-G2 cells. The overall results demonstrated the behavior of liposomes and nanoemulsions complexed with a plasmid or a mixture of a plasmid and an oligonucleotide, and demonstrated that the association with one or two nucleic acids sequences of different length does not seem to interfere in the physicochemical characteristics of complexes or in the uptake capacity by three different types of cells.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; Co-complexation; Liposome; Microfluidization; Nanoemulsion; Plasmid and oligonucleotide

Mesh:

Substances:

Year:  2018        PMID: 29982016     DOI: 10.1016/j.jcis.2018.06.058

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  4 in total

1.  Vortioxetine liposomes as a novel alternative to improve drug stability under stress conditions: toxicity studies and evaluation of antidepressant-like effect.

Authors:  Caroline Hermann Nodari; Natália Dalanhol De Quadros; Raquel Chiarentin; Francini Pereira Da Silva; Fernando Dal Pont Morisso; Mariele Feiffer Charão; Juliane Deise Fleck; Cristiane Bastos De Mattos; Andresa Heemann Betti; Simone Gasparin Verza
Journal:  Pharmacol Rep       Date:  2022-09-09       Impact factor: 3.919

2.  Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy.

Authors:  Roselena Silvestri Schuh; Juliana Bidone; Edina Poletto; Camila Vieira Pinheiro; Gabriela Pasqualim; Talita Giacomet de Carvalho; Mirian Farinon; Dirnete da Silva Diel; Ricardo Machado Xavier; Guilherme Baldo; Ursula Matte; Helder Ferreira Teixeira
Journal:  Pharm Res       Date:  2018-09-26       Impact factor: 4.200

3.  Production of antimicrobial metabolites against pathogenic bacteria and yeasts by Fusarium oxysporum in submerged culture processes.

Authors:  Liliane Poleto; Letícia Osório da Rosa; Roselei Claudete Fontana; Eliseu Rodrigues; Édina Poletto; Guilherme Baldo; Suelen Paesi; Ceci Sales-Campos; Marli Camassola
Journal:  Bioprocess Biosyst Eng       Date:  2021-03-01       Impact factor: 3.210

Review 4.  Advances in CRISPR/Cas9.

Authors:  Youmin Zhu
Journal:  Biomed Res Int       Date:  2022-09-23       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.